ClinicalTrials.Veeva

Menu

Entire Papilla Preservation Technique With and Without Biomaterials in the Treatment of Isolated Intrabony Defects

D

Dr. Aslan Private Perio Center

Status

Completed

Conditions

Periodontal Diseases

Treatments

Device: Bone substitutes application
Procedure: Procedure: Periodontal surgery with entire papilla preservation (EPP) technique
Device: EMD application

Study type

Interventional

Funder types

Other

Identifiers

NCT03923465
AslanPPC_RCT_01

Details and patient eligibility

About

The aim of this study is to investigate the clinical efficacy of entire papilla preservation technique with and without the adjunct of amelogenins (EMD) and bone substitutes.

Full description

The present study is designed as a single-centre, parallel group, randomized, controlled clinical trial comparing the efficacy of EPP with or without biomaterials. Each patient will contribute with a single intrabony defect. Three months after completion of initial periodontal therapy, all the experimental sites will be accessed with the "EPP" technique (Aslan et al., 2017a) and carefully debrided. EDTA gel will be applied on the instrumented root surfaces. A combination of EMD and deproteinized bovine-derived bone substitute will be applied in the test group (EPP EMD + BS), while the control group (EPP) will not receive any regenerative biomaterial. Patients will be enrolled in a stringent maintenance programme with recalls on a weekly basis for the first month and then monthly controls for professional tooth cleaning up to 1 year. Clinical parameters will be recorded immediately before regenerative surgery (baseline) and 12 months after the regenerative periodontal surgery.

Enrollment

30 patients

Sex

All

Ages

18 to 65 years old

Volunteers

No Healthy Volunteers

Inclusion criteria

  • Systemically healthy
  • Clinical diagnosis of advanced periodontitis
  • Having one isolated intrabony defect with probing depth (PD) ≥7 mm, clinical attachment level (CAL) ≥8 mm and at least 4 mm intrabony component involving predominantly the interproximal area of the affected tooth.
  • Full-mouth plaque score (FMPS) ≤20%.
  • Full-mouth bleeding score (FMBS) ≤20%.

Exclusion criteria

  • Smokers
  • Patients with known systemic diseases such as diabetes and cardiovascular diseases or using medications that affect periodontal tissues, pregnant or lactating women
  • One-wall intrabony defects
  • Defects that involve buccal and lingual sites
  • Presence of inadequate endodontic treatment and/or restoration in the relevant teeth.

Trial design

Primary purpose

Treatment

Allocation

Randomized

Interventional model

Parallel Assignment

Masking

Double Blind

30 participants in 2 patient groups

EPP with EMD+BS
Active Comparator group
Description:
Using minimally invasive surgery, entire papilla preservation technique with the adjunctive use of amelogenins and bone substitutes
Treatment:
Device: EMD application
Procedure: Procedure: Periodontal surgery with entire papilla preservation (EPP) technique
Device: Bone substitutes application
EPP without EMD+BS
Other group
Description:
Using minimally invasive surgery, entire papilla preservation technique without the adjunctive use of amelogenins and bone substitutes
Treatment:
Procedure: Procedure: Periodontal surgery with entire papilla preservation (EPP) technique

Trial contacts and locations

0

Loading...

Data sourced from clinicaltrials.gov

Clinical trials

Find clinical trialsTrials by location
© Copyright 2026 Veeva Systems